Varaico: Literature-Extracted Genetic Variants

Gene:SCN5A
Variant:p.T353I
Back to variants list

SCN5A

NM_000335.5:p.T353I

Associated Papers

Scalable approaches for generating, validating and incorporating data from high-throughput functional assays to improve clinical variant classification.

Padigepati SR et al.

Human Genetics, 2024

39085601 (PubMed )
Supplement: 439_2024_2691_MOESM2_ESM.xlsx › SCN5A

Biophysical mechanisms of myocardium sodium channelopathies.

Zaytseva AK et al.

Pflugers Archiv : European Journal of Physiology, 2024

Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome.

Zhao Z et al.

Ebiomedicine, 2024

Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights.

Frosio A et al.

International Journal of Molecular Sciences, 2023

Gene variant effects across sodium channelopathies predict function and guide precision therapy.

Brunklaus A et al.

Brain : a Journal of Neurology, 2022

35037686 (PubMed )
Supplement: awac006_Supplementary_Data.pdf

Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome.

Zaytseva AK et al.

Biochemistry and Biophysics Reports, 2022

Comparative structural analysis of human Nav1.1 and Nav1.5 reveals mutational hotspots for sodium channelopathies.

Pan X et al.

Proceedings of the National Academy of Sciences of the United States of America, 2021

Multiple mechanisms underlie increased cardiac late sodium current.

Kroncke BM et al.

Heart Rhythm, 2019

Experimental Models of Brugada syndrome.

Sendfeld F et al.

International Journal of Molecular Sciences, 2019

31032819 (PubMed )
Supplement: ijms-20-02123-s001.pdf

Predicting changes to INa from missense mutations in human SCN5A.

Clerx M et al.

Scientific Reports, 2018

30143662 (PubMed )
Supplement: 41598_2018_30577_MOESM1_ESM.pdf

Therapeutic Strategies Targeting Inherited Cardiomyopathies.

Varian K et al.

Current Heart Failure Reports, 2017

Brugada syndrome: a fatal disease with complex genetic etiologies - still a long way to go.

Wu Y et al.

Forensic Sciences Research, 2017

Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.

Zhang J et al.

European Journal of Pharmacology, 2015

Utilizing multiple in silico analyses to identify putative causal SCN5A variants in Brugada syndrome.

Juang JM et al.

Scientific Reports, 2014

24463578 (PubMed )
Supplement: srep03850-s1.pdf

A novel missense mutation, I890T, in the pore region of cardiac sodium channel causes Brugada syndrome.

Tarradas A et al.

Plos One, 2013

23308164 (PubMed )
Supplement: pone.0053220.s002.doc

A novel strategy using cardiac sodium channel polymorphic fragments to rescue trafficking-deficient SCN5A mutations.

Shinlapawittayatorn K et al.

Circulation. Cardiovascular Genetics, 2011

A sodium channel pore mutation causing Brugada syndrome.

Pfahnl AE et al.

Heart Rhythm, 2007

Just another Brugada syndrome mutation?

Napolitano C

Heart Rhythm, 2007

Changes in action potentials and intracellular ionic homeostasis in a ventricular cell model related to a persistent sodium current in SCN5A mutations underlying LQT3.

Christé G et al.

Progress in Biophysics and Molecular Biology, 0

SCN5A channelopathies--an update on mutations and mechanisms.

Zimmer T et al.

Progress in Biophysics and Molecular Biology, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."